InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: NASDAQ2020 post# 234098

Sunday, 11/20/2016 1:26:49 PM

Sunday, November 20, 2016 1:26:49 PM

Post# of 403541
Incorrect. Thankfully.



All of the ANDAS from Mikah are FDA approved.
Just need site transfers and launch approval.







The only possible saving grace for shareholders is the mystery unapproved ANDA. It is the only reason I value these generics at ~$3 million instead of ~$1 million. I am hopeful that whatever it is, it will be good. If it was really, really good- then you'd hear more about it. Whatever it is, it might be approved any day.





http://ir.elitepharma.com/profiles/investor/newsPdf.asp?c=1053369&ID=1053369/000114420416108327/v441688_10k.htm&m=sec

Elite’s Acquisition of 13 Abbreviated New Drug Applications

On August 1, 2013, Elite executed an asset purchase agreement (the “Mikah ANDA Purchase”) with Mikah and acquired from Mikah a total of 13
ANDAs, consisting of 12 ANDAs approved by the FDA and one ANDA under active review with the FDA
, and all amendments thereto (the
“Mikah 13 ANDA Acquisition”) for aggregate consideration of $10,000,000, payable pursuant to a secured convertible note due in August 2016.








Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News